Option Care Health (NASDAQ:OPCH) Releases Earnings Results, Beats Expectations By $0.04 EPS

Option Care Health (NASDAQ:OPCHGet Free Report) posted its earnings results on Tuesday. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04, Briefing.com reports. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The firm had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same period last year, the firm earned $0.21 EPS. The company’s quarterly revenue was up 12.8% on a year-over-year basis. Option Care Health updated its FY 2024 guidance to EPS.

Option Care Health Stock Performance

NASDAQ OPCH opened at $29.93 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.33. Option Care Health has a 1 year low of $24.23 and a 1 year high of $35.74. The company has a market capitalization of $5.20 billion, a PE ratio of 19.69, a P/E/G ratio of 1.74 and a beta of 1.22. The company has a fifty day moving average of $32.13 and a two-hundred day moving average of $31.52.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the firm’s stock in a transaction on Monday, February 26th. The stock was bought at an average price of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the purchase, the director now directly owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a report on Wednesday. Jefferies Financial Group lifted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research report on Monday, March 4th.

Check Out Our Latest Report on OPCH

About Option Care Health

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Further Reading

Earnings History for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.